Atorvastatin calcium and Ascorbate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atorvastatin calcium (atorvastatin calcium) and Ascorbate (vitamin c (ascorbic acid)). Common drug interactions include pigmentation disorder among females and amnesia among males.

The phase IV clinical study analyzes what interactions people have when they take Atorvastatin calcium and Ascorbate. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,309 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

What is Ascorbate?

Ascorbate has active ingredients of vitamin c (ascorbic acid). eHealthMe is studying from 1,446 Ascorbate users. Check the latest studies of Ascorbate.



On Jul, 21, 2026

72 people who take Atorvastatin calcium and Ascorbate together, and have interactions are studied.

Atorvastatin calcium and Ascorbate drug interactions.

What are the common drug interactions of Atorvastatin Calcium and Ascorbate, by gender? *:

female:

  1. Pigmentation disorder (disturbances of human skin colour)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Skin discolouration (change of skin colour)
  4. Stress
  5. Tooth fracture
  6. Drug ineffective
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Asthma
  9. Dyspnoea (difficult or laboured respiration)
  10. Dyspnoea exertional (breathlessness or shortness of breath)

male:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Diarrhoea
  3. Confusional state
  4. Decreased appetite
  5. Disease progression
  6. Dizziness
  7. Drug ineffective
  8. Gait disturbance
  9. Head injury
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Atorvastatin Calcium and Ascorbate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthma
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Dyspnoea (difficult or laboured respiration)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  8. Nasal obstruction (blockage of nose)
  9. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  10. Respiratory tract infection

50-59:

  1. Asthenia (weakness)
  2. Disease recurrence
  3. Iron deficiency anaemia
  4. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  5. Oral herpes (viral infection of mouth)
  6. Pain in extremity
  7. Pyrexia (fever)
  8. Drug ineffective
  9. Ear pain
  10. Eye infection

60+:

  1. Abdominal pain
  2. Drug ineffective
  3. Frequent bowel movements
  4. Haematochezia (passage of stools containing blood)
  5. Headache (pain in head)
  6. Infusion related reaction
  7. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nausea (feeling of having an urge to vomit)
  10. Oral candidiasis (fungal infection of mouth)

What are the existing conditions these people have? *

  1. Asthma: 29 people, 40.28%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 17 people, 23.61%
  3. Allergies: 10 people, 13.89%
  4. Nausea (feeling of having an urge to vomit): 9 people, 12.50%
  5. Multiple Myeloma (cancer of the plasma cells): 6 people, 8.33%
  6. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 6.94%
  7. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Atorvastatin calcium and Ascorbate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atorvastatin calcium and Ascorbate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ascorbate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atorvastatin calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ascorbate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium and vitamin c (ascorbic acid) (the active ingredients of Atorvastatin calcium and Ascorbate, respectively), and Atorvastatin calcium and Ascorbate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: